Claim and contextHow the claim confuses the evidence
This page records a recurring claim rather than the discovery of a molecule. FDA’s compounding safety assessments illustrate the problem: peptide-related substances can have limited human safety information and concerns about immune reactions or impurities. FDA substance-specific assessments.
Everywhere · Timeless error
Book of the Canon · comic scriptureThe laboratory legend
The claim entered dressed in a white coat and said natural three times. The Inspection Desk asked for identity, sterility, dose, and evidence; the coat immediately fled.
This bold passage is invented comedy, not scientific or historical fact.Editorial recordProfile editorial revision: October 4, 2026Prepared under the Church of Peptides evidence standardEditorial review: Church of PeptidesIndependent clinical review: none to dateContent evidence reviewed: September 12, 2026
Evidence ledgerSources
Source links checked: October 4, 2026. Being a peptide does not establish a product’s safety, quality or regulatory status.
- FDA: bulk substances that may present significant safety risks
- FDA Drugs@FDA database
Fiction disclosure: The bold laboratory legend is invented. The historical and scientific sections are factual summaries; no invented connective events were added.
Educational entertainment only. Not medical advice, diagnosis, dosing guidance, or a recommendation to obtain or use a product.